Lower riskDrug recall · FDA · Published August 19, 2026
American Health Packaging Buprenorphine Tablets Recall: Label Mix-Up Hazard
American Health Packaging recalls 2mg Buprenorphine Sublingual Tablets (C-III) due to labeling mix-up. This may cause confusion with similar products. Check carton NDC 60687-481-21 for affected items.
“American Health Packaging Buprenorphine Tablets Recall: Label Mix-Up Hazard.” GovInfoNow, updated September 23, 2026. https://govinfonow.com/recall/1004693-american-health-packaging-buprenorphine-tablets-recall-label-mix-up-hazard. Based on FDA recall #D-0840-2026 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0840-2026%22&limit=1).
The Food and Drug Administration announced on Aug. 19, 2026, that American Health Packaging is voluntarily recalling Buprenorphine Sublingual Tablets due to a labeling mix-up hazard. Owners should contact the company for a refund.
Distributed by: American Health Packaging, Columbus, Ohio 43217
Distribution: US Nationwide
Units affected: 10,953 cartons
The hazard
The recall involves a labeling mix-up for the drug product. The FDA classified this as a Class III recall, indicating it is not likely to cause adverse health consequences but violates labeling regulations.
Context
GovInfoNow's records show American Health Packaging has 41 other recalls on record since July 23, 2012. Other recent recalls of similar products include American Regent Levocarnitine Injection Recall: Missing Label Hazard (April 16, 2026), Sun Pharmaceutical Perampanel 6mg Tablets Recall: Label Mix-Up Risk (June 17, 2026), and Par Health Buprenorphine Injection Recall: Crystallization Risk (June 12, 2026).
How to tell if you have this one
Check the carton label for NDC 60687-481-21. The product is a 2mg Buprenorphine Sublingual Tablet (C-III) with 30 tablets (3x10) and expires June 30, 2027.
Brand
American Health Packaging
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Product Label
Look for the carton NDC number 60687-481-21 on the product packaging.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “US Nationwide.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA published this recall 21 days after the firm started it.
1Firm started the recall
2Published in FDA’s Enforcement Report
3FDA classified it Class III
4Added to GovInfoNow
Dates from the agency record only; steps without a date are left out.
The recall is due to a labeling mix-up, not a safety issue. The product is safe to use if the correct label is present.
What should I do if I have the recalled product?
The recall does not require immediate action. Check the product label to confirm if it matches the NDC 60687-481-21. If unsure, contact your healthcare provider.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0840-2026 (August 19, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0840-2026 to see it in context.
Plain-language summary written by qwen3:4b on September 23, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.